{"id":170,"date":"2021-07-06T15:57:25","date_gmt":"2021-07-06T15:57:25","guid":{"rendered":"https:\/\/ajitpawar1119-work.colibriwp.com\/nova-medical-research\/?p=170"},"modified":"2021-07-06T15:57:25","modified_gmt":"2021-07-06T15:57:25","slug":"artificial-intelligence-in-genomics-market-is-expected-to-exceed-us-2675-million-by-2027","status":"publish","type":"post","link":"https:\/\/ajitpawar1119-work.colibriwp.com\/nova-medical-research\/artificial-intelligence-in-genomics-market-is-expected-to-exceed-us-2675-million-by-2027\/","title":{"rendered":"Artificial Intelligence In Genomics Market is Expected to Exceed US$ 2,675 million By 2027"},"content":{"rendered":"

NEW YORK<\/strong> \u2013 Nova one advisor recently added a research report, Artificial Intelligence In Genomics market – global industry size, share analysis, market dynamics, market risk factors, market opportunities and challenges. segment forecast and the geographical distribution of the global market, profitability graph and the regional outlook of this business vertical.<\/p>\n

Market Size; The global Artificial Intelligence In Genomics market size was valued at US$ 304 million in 2020 and is projected to reach US$ 2,675 million by 2027, rising at a market growth (CAGR) of 53.8% during the forecast period.<\/strong><\/p>\n

The need to control drug development and discovery costs and time, increasing public and private investments in AI in genomics, and the adoption of AI solutions in precision medicine are driving the growth of this market. However, the lack of a skilled AI workforce and ambiguous regulatory guidelines for medical software are expected to restrain the market growth during the forecast period.<\/p>\n

NOTE:<\/strong> Our report highlights the major issues and hazards that companies might come across due to the unprecedented outbreak of COVID-19.<\/p>\n

Request Coronavirus Impact Analysis on This Market@\u00a0https:\/\/www.novaoneadvisor.com\/report\/sample\/4303<\/a><\/strong><\/p>\n

A recent report provides crucial insights along with application based and forecast information in the Global Artificial Intelligence In Genomics Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Artificial Intelligence In Genomics market.<\/p>\n

With increasing cases of obesity all over the globe, a need for conducting an in-depth study about this healthcare issue led to the development of this report. Increasing binge eating and consumption of junk foods, neglect towards regular exercise, rising levels of stress, are key market drivers. The report discusses more information about these subjects, with a focus on the rising need for Artificial Intelligence In Genomics.<\/p>\n

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period. With healthcare being a sensitive topic, a separate analysis is included that discusses the widespread continuing obesity all over the globe consequently increasing demand for surgical devices.<\/p>\n

Highlights of the Report:<\/strong><\/p>\n

In-depth analysis of various insights, namely, Artificial Intelligence In Genomics Market trends, growth drivers, opportunities, and other related challenges.<\/p>\n

Comprehensive details of key market players, their core competencies, and Artificial Intelligence In Genomics Market share.<\/p>\n

The potency of suppliers and buyers to make better business decisions.<\/p>\n

Lists out the market size in terms of volume.<\/p>\n

Download This Full Research Report, Click Here@\u00a0https:\/\/www.novaoneadvisor.com\/report\/checkout\/4303<\/a><\/strong><\/p>\n

Companies and Manufacturers Covered<\/strong><\/p>\n

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analyzed and prime business strategies and products that offer high revenue generation capacities were indentified. Key players of the global Artificial Intelligence In Genomics market are included as given below:<\/p>\n

List of KEY PLAYERS in\u00a0Artificial Intelligence In Genomics\u00a0Market Report are:<\/strong><\/p>\n

IBM (US), Microsoft (US), NVIDIA Corporation (US), Deep Genomics (Canada), BenevolentAI (UK), Fabric Genomics Inc. (US), Verge Genomics (US), Freenome Holdings, Inc. (US), MolecularMatch Inc. (US), Cambridge Cancer Genomics (UK), SOPHiA GENETICS (US), Data4Cure Inc. (US), PrecisionLife Ltd (UK), Genoox Ltd. (US), Lifebit (UK), Diploid (Belgium), FDNA Inc. (US), DNAnexus Inc. (US), Empiric Logic (Ireland), and Engine Biosciences Pte. Ltd. (US).<\/p>\n

Unravelling the Critical Segments<\/strong><\/b><\/p>\n

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application\/end-user, and region.\u00a0Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:<\/p>\n

AI in genomics Market, by Offering\u00a0<\/strong><\/b><\/p>\n